(Total Views: 449)
Posted On: 01/02/2021 8:19:45 PM
Post# of 155052
Re: MD VIROLOGIST #70917
Good arguments against using all-cause mortality, in general.
Specifically, though, in this trial, two points speak directly to the op pieces concerns:
1) CD-12 really is an ICU trial - as noted, most aren't, and
2) Leronlimab will reduce SAEs (and their sequelae) vs. SOC
Specifically, though, in this trial, two points speak directly to the op pieces concerns:
1) CD-12 really is an ICU trial - as noted, most aren't, and
2) Leronlimab will reduce SAEs (and their sequelae) vs. SOC
(3)
(0)
